 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Arcutis Biotherapeutics Inc. (ARQT)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-04 Purchase | 2020-02-06 4:26 pm | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 294,117 | $17 | $4,999,989 | 3,979,292 (Indirect) | View |
| 2020-02-04 Purchase | 2020-02-06 11:27 am | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 500,000 | $17 | $8,500,000 | 10,542,790 (Indirect) | View |
| 2020-02-04 Purchase | 2020-02-06 10:29 am | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 500,000 | $17 | $8,500,000 | 10,542,790 (Direct) | View |
| 2020-02-03 Purchase | 2020-02-04 5:30 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 558,888 | $17 | $9,501,096 | 176,500 (Indirect) | View |
| 2020-02-03 Purchase | 2020-02-04 5:27 pm | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 558,888 | $17 | $9,501,096 | 176,500 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-13 Exercise | 2020-03-16 6:05 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 59,481 | $1.681 | 158,492 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 6:05 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 59,481 | $1.681 | 158,492 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 6:04 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 6,110 | $0.5802 | 36,660 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 6:04 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 6,110 | $0.5802 | 36,660 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-04 4:42 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Sun Ricky Director | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 9,000 | $0 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:13 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 12,000 | $27.61 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 29,000 | $0 | 65,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:12 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 65,000 | $27.61 | 65,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:10 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 9,000 | $0 | 27,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:10 pm | N/A 2030-03-27 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 27,000 | $27.61 | 27,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:09 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 9,000 | $0 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:09 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 12,000 | $27.61 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:08 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 9,000 | $0 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:06 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 12,000 | $27.61 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:05 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 9,000 | $0 | 27,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:05 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 27,000 | $27.61 | 27,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:02 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 8:59 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | ESTES DANIEL Director | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 8:57 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 4:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 2,825,602 | $0 | 3,979,292 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 4:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 859,573 | $0 | 3,979,292 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 4:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 2,825,602 | $0 | 3,979,292 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 4:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 859,573 | $0 | 3,979,292 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 11:27 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 6,360,272 | $0 | 10,542,790 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 11:27 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 2,099,019 | $0 | 10,542,790 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 11:27 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 1,074,467 | $0 | 10,542,790 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 11:27 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 6,360,272 | $0 | 10,542,790 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 11:27 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 2,099,019 | $0 | 10,542,790 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 11:27 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 1,074,467 | $0 | 10,542,790 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-06 10:29 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 6,360,272 | $0 | 10,542,790 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 10:29 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 2,099,019 | $0 | 10,542,790 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 10:29 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 1,074,467 | $0 | 10,542,790 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 10:29 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 6,360,272 | $0 | 10,542,790 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 10:29 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 2,099,019 | $0 | 10,542,790 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 10:29 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N 10% Owner | 1,074,467 | $0 | 10,542,790 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:28 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 24,991 | $0 | 0 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-04 6:28 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 24,991 | $0 | 0 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-04 6:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 99,964 | $0 | 0 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 49,981 | $0 | 0 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-04 6:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 99,964 | $0 | 0 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 49,981 | $0 | 0 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-04 6:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 37,486 | $0 | 0 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 49,981 | $0 | 0 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-04 6:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 37,486 | $0 | 0 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 49,981 | $0 | 0 (Indirect) | View |
| 2020-02-04 Conversion | 2020-02-04 6:24 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 24,991 | $0 | 0 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:24 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 24,991 | $0 | 0 (Direct) | View |
| 2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2,825,603 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 859,573 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 429,786 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2,825,603 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 859,573 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 429,786 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 2,825,603 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 859,573 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 429,786 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 2,825,603 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 859,573 | $0 | 176,500 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-04 5:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 429,786 | $0 | 176,500 (Indirect) | View |
| 2020-01-30 Option Award | 2020-02-03 7:56 pm | N/A 2030-01-30 | Arcutis Biotherapeutics Inc. | ARQT | TURNER JOSEPH L Director | 37,500 | $17 | 37,500 (Direct) | View |